12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga Insights 13 hours ago

Movers

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus (NASDAQ:CERS) shares

Gainers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million.
  • Cerus (NASDAQ:CERS) shares increased by 13.48% to $2.68. The market value of their outstanding shares is at $459.4 million. The company's, Q3 earnings came out today.
  • Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 8.23% to $5.39. The company's market cap stands at $4.5 million.
  • Accendra Health (NYSE:ACH) stock moved upwards by 6.26% to $0.28. The company's market cap stands at $19.4 million.
  • Autonomix Medical (NASDAQ:AMIX) shares increased by 5.95% to $1.78. The market value of their outstanding shares is at $3.5 million.
  • Can Fite Biopharma (AMEX:CANF) shares moved upwards by 4.38% to $1.7. The company's market cap stands at $3.4 million.

Losers

  • Baird Medical Investment (NASDAQ:BDMD) shares decreased by 8.0% to $0.13 during Monday's after-market session. The market value of their outstanding shares is at $5.1 million.
  • Theriva Biologics (AMEX:TOVX) stock declined by 5.21% to $0.18. The market value of their outstanding shares is at $7.8 million.
  • Inovio Pharmaceuticals (NASDAQ:INO) stock decreased by 4.2% to $1.82. The company's market cap stands at $62.2 million.
  • Travere Therapeutics (NASDAQ:TVTX) stock declined by 4.09% to $47.25. The market value of their outstanding shares is at $4.6 billion. As per the news, the Q3 earnings report came out today.
  • Acumen Pharmaceuticals (NASDAQ:ABOS) stock decreased by 3.88% to $0.23. The company's market cap stands at $15.1 million.
  • CDT Equity (NASDAQ:CDT) shares fell 3.86% to $0.07. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Read the original